These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26581881)

  • 1. Metabolic Control With the Bio-inspired Artificial Pancreas in Adults With Type 1 Diabetes: A 24-Hour Randomized Controlled Crossover Study.
    Reddy M; Herrero P; Sharkawy ME; Pesl P; Jugnee N; Pavitt D; Godsland IF; Alberti G; Toumazou C; Johnston DG; Georgiou P; Oliver NS
    J Diabetes Sci Technol; 2015 Nov; 10(2):405-13. PubMed ID: 26581881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.
    Haidar A; Legault L; Dallaire M; Alkhateeb A; Coriati A; Messier V; Cheng P; Millette M; Boulet B; Rabasa-Lhoret R
    CMAJ; 2013 Mar; 185(4):297-305. PubMed ID: 23359039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fully artificial pancreas versus a hybrid artificial pancreas for type 1 diabetes: a single-centre, open-label, randomised controlled, crossover, non-inferiority trial.
    Tsoukas MA; Majdpour D; Yale JF; Fathi AE; Garfield N; Rutkowski J; Rene J; Legault L; Haidar A
    Lancet Digit Health; 2021 Nov; 3(11):e723-e732. PubMed ID: 34580055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility study of a bio-inspired artificial pancreas in adults with type 1 diabetes.
    Reddy M; Herrero P; El Sharkawy M; Pesl P; Jugnee N; Thomson H; Pavitt D; Toumazou C; Johnston D; Georgiou P; Oliver N
    Diabetes Technol Ther; 2014 Sep; 16(9):550-7. PubMed ID: 24801544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single-blind, randomised, crossover study to reduce hypoglycaemia risk during postprandial exercise with closed-loop insulin delivery in adults with type 1 diabetes: announced (with or without bolus reduction) vs unannounced exercise strategies.
    Tagougui S; Taleb N; Legault L; Suppère C; Messier V; Boukabous I; Shohoudi A; Ladouceur M; Rabasa-Lhoret R
    Diabetologia; 2020 Nov; 63(11):2282-2291. PubMed ID: 32740723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outpatient 60-hour day-and-night glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or sensor-augmented pump therapy in adults with type 1 diabetes: An open-label, randomised, crossover, controlled trial.
    Haidar A; Messier V; Legault L; Ladouceur M; Rabasa-Lhoret R
    Diabetes Obes Metab; 2017 May; 19(5):713-720. PubMed ID: 28094472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies.
    Hovorka R; Kumareswaran K; Harris J; Allen JM; Elleri D; Xing D; Kollman C; Nodale M; Murphy HR; Dunger DB; Amiel SA; Heller SR; Wilinska ME; Evans ML
    BMJ; 2011 Apr; 342():d1855. PubMed ID: 21493665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fully automated closed-loop insulin delivery in adults with type 2 diabetes: an open-label, single-center, randomized crossover trial.
    Daly AB; Boughton CK; Nwokolo M; Hartnell S; Wilinska ME; Cezar A; Evans ML; Hovorka R
    Nat Med; 2023 Jan; 29(1):203-208. PubMed ID: 36631592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump Therapy in Older Adults With Type 1 Diabetes (ORACL): A Randomized, Crossover Trial.
    McAuley SA; Trawley S; Vogrin S; Ward GM; Fourlanos S; Grills CA; Lee MH; Alipoor AM; O'Neal DN; O'Regan NA; Sundararajan V; Colman PG; MacIsaac RJ
    Diabetes Care; 2022 Feb; 45(2):381-390. PubMed ID: 34844995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Suboptimally Controlled Adolescents With Type 1 Diabetes: A 3-Week, Free-Living, Randomized Crossover Trial.
    Tauschmann M; Allen JM; Wilinska ME; Thabit H; Acerini CL; Dunger DB; Hovorka R
    Diabetes Care; 2016 Nov; 39(11):2019-2025. PubMed ID: 27612500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Closed-Loop Insulin Delivery for Adults with Type 1 Diabetes Undertaking High-Intensity Interval Exercise Versus Moderate-Intensity Exercise: A Randomized, Crossover Study.
    Jayawardene DC; McAuley SA; Horsburgh JC; Gerche A; Jenkins AJ; Ward GM; MacIsaac RJ; Roberts TJ; Grosman B; Kurtz N; Roy A; O'Neal DN
    Diabetes Technol Ther; 2017 Jun; 19(6):340-348. PubMed ID: 28574723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Deep Learning Framework for Automatic Meal Detection and Estimation in Artificial Pancreas Systems.
    Daniels J; Herrero P; Georgiou P
    Sensors (Basel); 2022 Jan; 22(2):. PubMed ID: 35062427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing the need for carbohydrate counting in type 1 diabetes using closed-loop automated insulin delivery (artificial pancreas) and empagliflozin: A randomized, controlled, non-inferiority, crossover pilot trial.
    Haidar A; Yale JF; Lovblom LE; Cardinez N; Orszag A; Falappa CM; Gouchie-Provencher N; Tsoukas MA; El Fathi A; Rene J; Eldelekli D; Lanctôt SO; Scarr D; Perkins BA
    Diabetes Obes Metab; 2021 Jun; 23(6):1272-1281. PubMed ID: 33528904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An In Silico Head-to-Head Comparison of the Do-It-Yourself Artificial Pancreas Loop and Bio-Inspired Artificial Pancreas Control Algorithms.
    Armiger R; Reddy M; Oliver NS; Georgiou P; Herrero P
    J Diabetes Sci Technol; 2022 Jan; 16(1):29-39. PubMed ID: 34861785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at home.
    Biester T; Nir J; Remus K; Farfel A; Muller I; Biester S; Atlas E; Dovc K; Bratina N; Kordonouri O; Battelino T; Philip M; Danne T; Nimri R
    Diabetes Obes Metab; 2019 Apr; 21(4):822-828. PubMed ID: 30478937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes.
    Ware J; Allen JM; Boughton CK; Wilinska ME; Hartnell S; Thankamony A; de Beaufort C; Schierloh U; Fröhlich-Reiterer E; Mader JK; Kapellen TM; Rami-Merhar B; Tauschmann M; Nagl K; Hofer SE; Campbell FM; Yong J; Hood KK; Lawton J; Roze S; Sibayan J; Bocchino LE; Kollman C; Hovorka R;
    N Engl J Med; 2022 Jan; 386(3):209-219. PubMed ID: 35045227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Bio-inspired Artificial Pancreas for Type 1 Diabetes Control in the Home: System Architecture and Preliminary Results.
    Herrero P; El-Sharkawy M; Daniels J; Jugnee N; Uduku CN; Reddy M; Oliver N; Georgiou P
    J Diabetes Sci Technol; 2019 Nov; 13(6):1017-1025. PubMed ID: 31608656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fully Closed-Loop Glucose Control Compared With Insulin Pump Therapy With Continuous Glucose Monitoring in Adults With Type 1 Diabetes and Suboptimal Glycemic Control: A Single-Center, Randomized, Crossover Study.
    Boughton CK; Hartnell S; Lakshman R; Nwokolo M; Wilinska ME; Ware J; Allen JM; Evans ML; Hovorka R
    Diabetes Care; 2023 Nov; 46(11):1916-1922. PubMed ID: 37616583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hybrid closed-loop glucose control compared with sensor augmented pump therapy in older adults with type 1 diabetes: an open-label multicentre, multinational, randomised, crossover study.
    Boughton CK; Hartnell S; Thabit H; Mubita WM; Draxlbauer K; Poettler T; Wilinska ME; Hood KK; Mader JK; Narendran P; Leelarathna L; Evans ML; Hovorka R
    Lancet Healthy Longev; 2022 Mar; 3(3):e135-e142. PubMed ID: 35359882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
    Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
    Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.